U.S. Tobacco Stock News

In the past few days, Tractor Supply reported fourth-quarter results that missed analyst earnings and revenue forecasts, while net sales still increased and operating income declined, alongside plans to open 100 new stores and a 4.3% annual dividend increase. A separate announcement from its Petsense and Allivet subsidiaries introduced a Pet Expert Advisory Council of veterinarians and pet wellness specialists, highlighting Tractor Supply’s push to deepen its role in comprehensive animal...

Why eXp World Holdings (EXPI) is on investors’ radar Recent trading in eXp World Holdings (EXPI) has drawn attention after a stretch of weak returns, including declines over the past month, past 3 months and year, prompting closer scrutiny of the stock. See our latest analysis for eXp World Holdings. At a share price of $6.84, eXp World Holdings has seen a 23.23% 1 month share price decline and a 30.79% 1 year total shareholder return decline. This suggests momentum has been fading as...

If you are wondering whether Nucor's share price still reflects good value or is already pricing in a lot of optimism, you are in the right place. Nucor's stock closed at US$176.07, with returns of 0.3% over 7 days, a 2.7% decline over 30 days, 3.9% year to date and 35.1% over 1 year. The 5 year return stands at 182.1% and the 3 year return at 6.1%. Recent headlines around Nucor have mainly focused on its position in the US steel industry and how investors are thinking about its long term...

Modine Manufacturing recently reported stronger-than-expected Q3 FY2026 results, highlighted by robust data center segment performance, raised full-year guidance, and a plan to spin off its Performance Technologies segment to sharpen focus on core thermal management solutions. This combination of better earnings, a clearer focus on higher-growth thermal applications, and a dedicated data center growth target of US$2.00 billion by FY2028 could meaningfully reshape how investors view the...

Why Baxter International (BAX) Is Back on Investors’ Radar Baxter International (BAX) has drawn fresh attention after its shares closed at $19.03, with mixed recent returns across the week, month, and past 3 months prompting investors to reassess the healthcare supplier. See our latest analysis for Baxter International. At a share price of $19.03, Baxter’s recent 7 day share price return of an 8.2% decline and year to date share price return of a 2.4% decline sit against a 1 year total...

In recent months, SELLAS Life Sciences Group reported encouraging activity for SLS009 in combination with AZA/VEN in relapsed/refractory AML and confirmed that the Independent Data Monitoring Committee recommended the Phase 3 REGAL trial continue without modification, with final analysis expected before year-end. This combination of positive efficacy signals and trial continuity strengthens the clinical credibility of SELLAS’s pipeline in a difficult-to-treat leukemia setting. We’ll now...

Why Bitdeer’s latest capital raise matters for shareholders Bitdeer Technologies Group (BTDR) has just raised fresh capital through a US$43.7 million follow on equity offering, shortly after completing a US$325 million convertible bond issue. This puts its funding decisions in focus for current and prospective shareholders. These back to back transactions give Bitdeer more financial resources to work with. However, they also introduce questions about dilution, future interest costs, and how...

DXC Technology recently outlined its renewed vision at the Morgan Stanley Technology, Media & Telecom Conference 2026, emphasizing a dual-track plan to upgrade core IT services and develop AI-enhanced offerings, including a refreshed Hogan core banking platform and a more modular approach to client solutions. The company also highlighted disciplined operational changes, such as exiting lower-margin work, streamlining its workforce, and favoring organic growth and acqui-hires over large...

Omnicell, ticker NasdaqGS:OMCL, is shifting its focus toward a software and services led model. The company recently acquired ANiGENT to deepen its capabilities in drug diversion detection within healthcare settings. This move marks a meaningful step in Omnicell's transition from a hardware vendor to a Healthcare IT company. Omnicell's pivot comes after a mixed share price record, with the stock at $41.53 and a value score of 4. The shares show a 9.8% gain over the past year, while longer...

LendingClub (LC) is drawing fresh attention after completing its shift to a fully regulated US bank, with recent earnings highlighting stabilizing margins, higher capital levels, and tighter loan origination focused on credit quality. See our latest analysis for LendingClub. The completed bank transition and recent earnings sit against a mixed trading backdrop, with a 5.05% 1 day share price return to $15.61 following weaker 30 and 90 day share price returns. At the same time, the 1 year...

Northern Oil and Gas (NOG) just released its fourth quarter and full year 2025 update, combining a large US$268,497,000 impairment charge with new 2026 production guidance, refreshed credit capacity, ongoing buybacks, and a maintained dividend. See our latest analysis for Northern Oil and Gas. That mix of a US$268.5m impairment, higher 2025 revenue and fresh 2026 production guidance has arrived alongside a 28.9% year to date share price return and a 1 year total shareholder return of 9.9%...

Tower Semiconductor (NasdaqGS:TSEM) is moving its partnership with Salience Labs into pre-production to manufacture PIC based OCS for AI data center infrastructure. The joint OCS solution is scheduled to be showcased at the OFC 2026 Conference, giving early visibility to potential customers in high performance AI networking. Tower is also expanding its work with Xanadu to support manufacturing for fault tolerant quantum computing hardware on its silicon photonics platform. Tower...

Why Noble Is On Investors' Radar Noble (NE), an offshore drilling contractor headquartered in Houston, has drawn attention after a strong stock move over the past month. This has prompted investors to recheck how its current valuation lines up with its fundamentals. See our latest analysis for Noble. Beyond the recent move, Noble’s 30 day share price return of 27.28% and year to date share price return of 58% sit alongside a 1 year total shareholder return of 116.6%. This indicates strong...

Cal-Maine Foods (NasdaqGS:CALM) has completed the acquisition of Creighton Brothers LLC and Crystal Lake LLC. The deal expands Cal-Maine's shell egg, egg products, and prepared foods operations into Indiana. The transaction adds production capacity and internal supply chain resources across conventional and specialty egg categories. For you as an investor, this move adds another piece to the Cal-Maine story as the company increases its presence across the U.S. egg market. NasdaqGS:CALM is a...

If you are wondering whether Ondas is still priced attractively after its recent run, this article will help you size up where the stock stands today. The share price closed at US$10.51, with a small 7 day gain of 2.0%, a 30 day return of 1.2% decline, a year to date return of 4.6% decline, and a very large 1 year return that is well over 10x. That kind of move tends to follow meaningful company updates, partnerships, financings, or regulatory milestones that change how investors think about...

Cadence Design Systems (NasdaqGS:CDNS) has filed a significant shelf registration, giving it the flexibility to issue securities in the future. The company is being highlighted as a key player in the expanding semiconductor IP market, where demand for licensed chip designs is increasing. These developments are drawing investor attention to Cadence's capital options and its role in a growing segment of the semiconductor ecosystem. Cadence Design Systems develops software and intellectual...

In late February 2026, Realty Income reported higher quarterly and full-year 2025 revenue and net income, issued 2026 earnings guidance of US$1.65–US$1.69 per share, and subsequently saw its stock rating cut to Hold from Buy by Freedom Capital Markets. Shortly after these updates, Realty Income also announced the planned departure of its Chief Legal Officer, underscoring both leadership transition and investor focus on how management will execute against modest 2026 guidance. We’ll now...

If you are wondering whether Essential Properties Realty Trust is reasonably priced or starting to look expensive, you are not alone. The stock last closed at US$34.57, with returns of 3.4% over 7 days, 14.8% over 30 days, 15.0% year to date and 12.0% over the past year, which naturally raises questions about what is already reflected in the price. Recent attention on Essential Properties Realty Trust has largely focused on its role as a net lease REIT and how that business model fits into...

The RealReal (REAL) just paired a strong fourth quarter with fresh 2026 guidance, reporting higher year over year revenue, narrower net losses and its first full year of consistently positive adjusted EBITDA. See our latest analysis for RealReal. After this earnings and guidance update, RealReal’s latest share price of $12.13 comes after mixed short term moves, with a 4.30% 1 day share price return but a 17.54% 30 day share price decline, while the 1 year total shareholder return of 111.88%...

If you are wondering whether Brookfield Infrastructure Partners is still good value at around US$38.94, the key question is how its current price lines up with what the underlying business might be worth. The unit price has been relatively firm recently, with a 6.3% move over the last 30 days and a 13.5% return year to date, while the 1 year return sits at 35.5% and the 5 year return at 39.8%. These moves sit against an ongoing stream of news about global infrastructure demand, financing...

Stevanato Group FY 2025 Earnings Snapshot Stevanato Group (NYSE:STVN) has put another solid quarter on the board for FY 2025, with Q3 revenue of €303.2 million and basic EPS of €0.13, alongside trailing twelve month EPS of €0.52 on €1.17 billion of revenue, capped by 22.6% earnings growth over the past year. The company has seen revenue move from €259.6 million in Q2 2024 to €303.2 million in Q3 2025, while quarterly EPS has ranged between €0.08 and €0.18 over that period, setting up a...

STAAR Surgical FY 2025 earnings snapshot STAAR Surgical (STAA) has wrapped up FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.37, keeping the focus firmly on the path back to profitability. The company has seen quarterly revenue range from US$42.6 million to US$94.7 million since the start of 2024, while basic EPS has swung between a loss of US$1.10 and a profit of US$0.20. This sets up a mixed picture on margins that investors may view as an ongoing turnaround story...

Strata Critical Medical (SRTA) has reported its FY 2025 numbers, with Q4 revenue at US$66.8 million and a basic EPS loss of US$0.06. Trailing twelve month revenue came in at US$197.1 million with a full year basic EPS loss of US$0.24. Over recent quarters, the company has reported revenue in a range from US$36.1 million to US$66.8 million, while quarterly basic EPS losses have moved between US$0.04 and US$0.12. This keeps the focus on how efficiently it is converting sales into earnings. With...

In late February 2026, UFP Technologies, Inc. extended and expanded its manufacturing supply agreement with Intuitive Surgical through December 31, 2029, while also reporting higher fourth-quarter and full-year 2025 sales and earnings compared with the prior year. This combination of a longer-term, higher-volume partnership with a key customer and recent earnings growth adds further visibility to UFP Technologies’ medical device exposure and contracted revenue base. Next, we’ll examine how...